Détails de la réservation
- Le : 7 February 2020
- De : 13 h 45
- à : 15 h 45
- Salle : Salle de conférence
Détails de l'évènement
David Eglin
AO Research Institute Davos (ARI) | AO Foundation
Clavadelerstrasse 8 | 7270 Davos | Switzerland
"Advanced Biomaterials and Biomanufacturing for Regenerative Therapies in Orthopaedics"
Abstract :
AO Research Institute Davos (ARI) ARI is the research arm of AO Foundation; its mission is promoting excellence in patient care and outcomes in trauma and musculoskeletal disorders. ARI's scientific activities are multidisciplinary and with a very strong approach to basic and translational research, focused towards clinical applications and realized through a cooperation network with many industrial partners. Within ARI, the Regenerative Orthopaedics Program (RO) is a multidisciplinary team focusing on a holistic approach to tissue engineering for repair and regeneration of traumatic injuries and degenerative disorders of the musculoskeletal system. The RO Program has established research activities in the field of bone, cartilage, and intervertebral disc, with a major focus on regenerative medicine, 3D printing, cell and gene therapy and fracture-related infections. The Biomedical Materials focus area team lead by Dr. David Eglin develops responsive materials for orthopaedic regeneration with notably a strong expertise on biopolymers and nanocomposites. Additive manufacturing technologies are used for both basic understanding of biomaterials and cells interaction, and for translational research in the orthopaedic field.
Invitation BIOTIS/LCPO
Responsable
- Nom : Bertrand Garbay